AstraZeneca shares rise as China probe update reassures
AstraZeneca shares rose today after the drugmaker said it could face a fine of up to $4.5m in China over suspected unpaid import taxes for two cancer drugs, reassuring analysts and investors that the business impact would be minor.
Business
• 06 Feb
